Cognition
Compound profile

Dihexa: Angiotensin IV Analogue and HGF/c-Met

Dihexa is a synthetic angiotensin IV analogue developed as a potent hepatocyte growth factor (HGF) / c-Met receptor agonist.

On this page

What it is

Dihexa is a synthetic hexapeptide developed at Washington State University. Derived from angiotensin IV but engineered for c-Met binding rather than AT4/IRAP.

Evidence snapshot

Category: Cognition. Status: Preclinical. See the references section below for the underlying primary sources.

Mechanism

Potently activates the c-Met receptor (the HGF receptor), triggering downstream signalling that promotes synaptic plasticity, dendritic spine formation, and neuronal survival.

Key research findings

In rodent models, dihexa enhances learning and memory, including in models of cognitive decline and traumatic brain injury.

Limits of the evidence

Very limited published work. Mechanism specificity needs more characterisation. Off-label use in nootropic contexts is widespread

Continue reading

Tissue Repair

BPC-157

Synthetic pentadecapeptide derived from a gastric juice protein, studied across hundreds of preclinical reports for tissue regeneration and cytoprotection.
Tissue Repair

TB-500 (Thymosin Beta-4 fragment)

Synthetic fragment of Thymosin Beta-4, a 43-amino-acid peptide investigated for its role in actin regulation, cell migration, and wound healing.
Peptide Protocols

BPC-157 + TB-500

Combined tissue-repair peptides with complementary mechanisms — the synergy hypothesis examined critically against the available preclinical record.
Growth Hormone · Research

Ipamorelin

Selective pentapeptide agonist of the growth hormone secretagogue receptor (GHSR-1a) studied for targeted GH release with minimal effect on cortisol, ACTH and prolactin.